Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
China flag China · Delayed Price · Currency is CNY
5.24
+0.02 (0.38%)
May 13, 2025, 3:00 PM CST

SHA:600998 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
2,9402,5072,1742,0852,4483,075
Upgrade
Depreciation & Amortization
804.58804.58774.94736.28656.81514.33
Upgrade
Other Amortization
101.93101.9341.5146.2646.7442.29
Upgrade
Loss (Gain) From Sale of Assets
424.2424.2-6.92-48.23-6.72-258.03
Upgrade
Asset Writedown & Restructuring Costs
12.4912.492.992.562.350.69
Upgrade
Loss (Gain) From Sale of Investments
-1,192-1,19237.4-308.25-1,456-1,231
Upgrade
Provision & Write-off of Bad Debts
24.1324.13131.87160.56201.32184.7
Upgrade
Other Operating Activities
1,0521,1581,0981,6421,3691,481
Upgrade
Change in Accounts Receivable
-4,615-4,6151,476-4,446-2,971-4,159
Upgrade
Change in Inventory
-2,671-2,671-2,828-1,633-720.4-737.5
Upgrade
Change in Accounts Payable
6,6806,6801,8805,9333,7244,305
Upgrade
Change in Other Net Operating Assets
87.1487.14104.494.36--
Upgrade
Operating Cash Flow
3,4083,0834,7483,9863,4593,444
Upgrade
Operating Cash Flow Growth
-17.19%-35.07%19.10%15.24%0.44%24.42%
Upgrade
Capital Expenditures
-1,188-975.42-1,049-1,243-1,386-1,457
Upgrade
Sale of Property, Plant & Equipment
22.7622.82163.42160.85171.49298.62
Upgrade
Cash Acquisitions
-35.9-34.55-79.5-286.29-28.5882.51
Upgrade
Divestitures
2,444743.5147.18126.75-22.72-79.56
Upgrade
Investment in Securities
-4,812-4,478-774.572,805-1,382-195.33
Upgrade
Other Investing Activities
4,0953,130331.16-75.28105.375.96
Upgrade
Investing Cash Flow
526.44-1,592-1,3611,488-2,543-1,275
Upgrade
Short-Term Debt Issued
---3,2803,311913.2
Upgrade
Long-Term Debt Issued
-17,03717,77219,74818,46722,392
Upgrade
Total Debt Issued
18,01017,03717,77223,02821,77723,306
Upgrade
Short-Term Debt Repaid
--2,864-4,251-1,582-1,004-1,521
Upgrade
Long-Term Debt Repaid
--18,711-18,122-23,295-20,258-22,905
Upgrade
Total Debt Repaid
-21,948-21,575-22,373-24,877-21,263-24,425
Upgrade
Net Debt Issued (Repaid)
-3,937-4,538-4,601-1,849514.42-1,120
Upgrade
Issuance of Common Stock
1,7761,776461.59195.35143.68-
Upgrade
Repurchase of Common Stock
-268.15-268.15--425.76-0.11-300.01
Upgrade
Common Dividends Paid
-1,417-1,554-1,635-1,388-1,682-737.68
Upgrade
Other Financing Activities
1,9982,0845,537-1,433-993.651,974
Upgrade
Financing Cash Flow
-1,849-2,500-2,237-4,901-2,017-183.54
Upgrade
Foreign Exchange Rate Adjustments
0.020.16-1.019.6-3.5-3.48
Upgrade
Net Cash Flow
2,086-1,0091,149582.99-1,1051,982
Upgrade
Free Cash Flow
2,2202,1073,6992,7432,0731,987
Upgrade
Free Cash Flow Growth
-29.63%-43.04%34.86%32.32%4.33%26.09%
Upgrade
Free Cash Flow Margin
1.45%1.39%2.46%1.95%1.69%1.79%
Upgrade
Free Cash Flow Per Share
0.440.420.730.520.400.37
Upgrade
Cash Income Tax Paid
3,2602,8843,0192,5712,2951,920
Upgrade
Levered Free Cash Flow
1,3981,3931,2902,9622,729-802.28
Upgrade
Unlevered Free Cash Flow
2,1602,1952,1133,7253,445-160.13
Upgrade
Change in Net Working Capital
84.08274.42291.97-1,723-2,1181,639
Upgrade
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.